| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.42e-06 | 2 | 47 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.42e-06 | 2 | 47 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.62e-05 | 3 | 47 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | deaminase binding | 3.24e-05 | 4 | 47 | 2 | GO:1990827 | |
| GeneOntologyMolecularFunction | methylated histone binding | 4.97e-05 | 86 | 47 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SFMBT1 NOLC1 HNRNPCL1 RERE KDM5A CREBBP EP300 WNK3 HNRNPCL2 SYNE2 SH3KBP1 ZMYND8 | 5.16e-05 | 1356 | 47 | 12 | GO:0060090 |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 5.43e-05 | 88 | 47 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SFMBT1 NOLC1 HNRNPCL1 RERE KDM5A CREBBP EP300 WNK3 HNRNPCL2 SYNE2 ZMYND8 | 6.09e-05 | 1160 | 47 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 8.09e-05 | 6 | 47 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.20e-04 | 206 | 47 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 3.86e-04 | 265 | 47 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 5.58e-04 | 15 | 47 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 5.58e-04 | 15 | 47 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | p53 binding | 7.91e-04 | 77 | 47 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 9.06e-04 | 875 | 47 | 8 | GO:0019904 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.11e-03 | 21 | 47 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.45e-03 | 24 | 47 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 1.57e-03 | 25 | 47 | 2 | GO:0070034 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.60e-03 | 739 | 47 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.83e-03 | 27 | 47 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.95e-03 | 562 | 47 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | dynein complex binding | 1.97e-03 | 28 | 47 | 2 | GO:0070840 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.04e-03 | 229 | 47 | 4 | GO:0003714 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.41e-03 | 31 | 47 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 2.62e-03 | 596 | 47 | 6 | GO:0140678 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.83e-03 | 120 | 47 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 2.90e-03 | 34 | 47 | 2 | GO:0008266 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 3.43e-03 | 37 | 47 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 3.47e-03 | 435 | 47 | 5 | GO:0004857 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 3.80e-03 | 39 | 47 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.37e-03 | 140 | 47 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.55e-03 | 303 | 47 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.42e-03 | 51 | 47 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 7.11e-03 | 167 | 47 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 7.18e-03 | 54 | 47 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 7.44e-03 | 55 | 47 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 8.80e-03 | 60 | 47 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 9.37e-03 | 62 | 47 | 2 | GO:0003678 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 9.96e-03 | 64 | 47 | 2 | GO:0140296 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.06e-02 | 66 | 47 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.06e-02 | 66 | 47 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 1.26e-02 | 206 | 47 | 3 | GO:0043021 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.45e-02 | 78 | 47 | 2 | GO:0008080 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.73e-05 | 896 | 47 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 3.04e-05 | 4 | 47 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 6.84e-05 | 999 | 47 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 7.58e-05 | 6 | 47 | 2 | GO:0090367 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 1.06e-04 | 7 | 47 | 2 | GO:0090365 | |
| GeneOntologyCellularComponent | nuclear body | FANCD2 NOLC1 NRDE2 PPIG RERE CMYA5 THOC2 SAP130 CREBBP S100PBP | 2.60e-05 | 903 | 47 | 10 | GO:0016604 |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 7.38e-05 | 6 | 47 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOLC1 CBX3 CHD8 HNRNPCL1 GCFC2 RERE THOC2 SAP130 CREBBP HNRNPCL2 SYNE2 | 1.87e-04 | 1377 | 47 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear speck | 3.90e-04 | 431 | 47 | 6 | GO:0016607 | |
| HumanPheno | Pilomatrixoma | 3.07e-06 | 9 | 18 | 3 | HP:0030434 | |
| HumanPheno | Keloids | 1.04e-05 | 13 | 18 | 3 | HP:0010562 | |
| HumanPheno | Plantar crease between first and second toes | 1.18e-05 | 2 | 18 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.18e-05 | 2 | 18 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.18e-05 | 2 | 18 | 2 | HP:0001042 | |
| HumanPheno | Skin appendage neoplasm | 2.93e-05 | 18 | 18 | 3 | HP:0012842 | |
| HumanPheno | Laryngeal cartilage malformation | 3.53e-05 | 3 | 18 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 3.53e-05 | 3 | 18 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 3.53e-05 | 3 | 18 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 3.53e-05 | 3 | 18 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 3.53e-05 | 3 | 18 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 3.53e-05 | 3 | 18 | 2 | HP:0005895 | |
| HumanPheno | Absent earlobe | 4.07e-05 | 20 | 18 | 3 | HP:0000387 | |
| HumanPheno | Blepharophimosis | 6.34e-05 | 129 | 18 | 5 | HP:0000581 | |
| HumanPheno | Trichiasis | 7.05e-05 | 4 | 18 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 7.05e-05 | 4 | 18 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 7.05e-05 | 4 | 18 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 7.05e-05 | 4 | 18 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 7.05e-05 | 4 | 18 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 7.05e-05 | 4 | 18 | 2 | HP:0031207 | |
| HumanPheno | Simple ear | 7.16e-05 | 24 | 18 | 3 | HP:0020206 | |
| HumanPheno | Cafe-au-lait spot | 8.45e-05 | 137 | 18 | 5 | HP:0000957 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.17e-04 | 5 | 18 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.17e-04 | 5 | 18 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.17e-04 | 5 | 18 | 2 | HP:0030421 | |
| HumanPheno | Abnormal hip joint morphology | 1.27e-04 | 490 | 18 | 8 | HP:0001384 | |
| HumanPheno | Broad eyebrow | 1.28e-04 | 29 | 18 | 3 | HP:0011229 | |
| HumanPheno | Hip dysplasia | 1.39e-04 | 247 | 18 | 6 | HP:0001385 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 1.42e-04 | 30 | 18 | 3 | HP:0005743 | |
| HumanPheno | Abnormal hip bone morphology | 1.47e-04 | 653 | 18 | 9 | HP:0003272 | |
| HumanPheno | Abnormal synovial membrane morphology | 1.53e-04 | 503 | 18 | 8 | HP:0005262 | |
| HumanPheno | Large foramen magnum | 1.75e-04 | 6 | 18 | 2 | HP:0002700 | |
| HumanPheno | Abnormal nasal dorsum morphology | 1.92e-04 | 262 | 18 | 6 | HP:0011119 | |
| HumanPheno | Deviated nasal septum | 2.45e-04 | 7 | 18 | 2 | HP:0004411 | |
| HumanPheno | Accessory spleen | 2.67e-04 | 37 | 18 | 3 | HP:0001747 | |
| HumanPheno | Motor stereotypy | 2.77e-04 | 280 | 18 | 6 | HP:0000733 | |
| HumanPheno | Convex nasal ridge | 2.84e-04 | 95 | 18 | 4 | HP:0000444 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | 3.50e-04 | 730 | 18 | 9 | HP:0002644 | |
| HumanPheno | Obesity | 3.78e-04 | 425 | 18 | 7 | HP:0001513 | |
| HumanPheno | Cervical cord compression | 4.18e-04 | 9 | 18 | 2 | HP:0002341 | |
| HumanPheno | Juvenile aseptic necrosis | 4.19e-04 | 43 | 18 | 3 | HP:0100323 | |
| HumanPheno | Spinal cord compression | 4.48e-04 | 44 | 18 | 3 | HP:0002176 | |
| HumanPheno | Ptosis | 4.49e-04 | 754 | 18 | 9 | HP:0000508 | |
| HumanPheno | Hypermelanotic macule | 5.12e-04 | 201 | 18 | 5 | HP:0001034 | |
| HumanPheno | Frontal hirsutism | 5.22e-04 | 10 | 18 | 2 | HP:0011335 | |
| HumanPheno | Lower extremity joint dislocation | 5.52e-04 | 318 | 18 | 6 | HP:0030311 | |
| HumanPheno | Abnormality of the thigh | 5.90e-04 | 322 | 18 | 6 | HP:0001439 | |
| HumanPheno | Overweight | 6.17e-04 | 49 | 18 | 3 | HP:0025502 | |
| HumanPheno | 11 pairs of ribs | 6.17e-04 | 49 | 18 | 3 | HP:0000878 | |
| HumanPheno | Self-injurious behavior | 6.27e-04 | 210 | 18 | 5 | HP:0100716 | |
| HumanPheno | Abnormal subclavian artery morphology | 6.37e-04 | 11 | 18 | 2 | HP:0031251 | |
| HumanPheno | Self-mutilation | 6.94e-04 | 51 | 18 | 3 | HP:0000742 | |
| HumanPheno | Single transverse palmar crease | 6.98e-04 | 215 | 18 | 5 | HP:0000954 | |
| HumanPheno | Upslanted palpebral fissure | 7.07e-04 | 333 | 18 | 6 | HP:0000582 | |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 7.35e-04 | 52 | 18 | 3 | HP:0009834 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 7.77e-04 | 53 | 18 | 3 | HP:0009906 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | FANCD2 APC RPGRIP1 CHD8 CEP295 CEP152 RERE CREBBP EP300 WNK3 | 8.15e-04 | 1008 | 18 | 10 | HP:0009122 |
| HumanPheno | Short thumb | 8.60e-04 | 127 | 18 | 4 | HP:0009778 | |
| HumanPheno | Facial grimacing | 8.99e-04 | 13 | 18 | 2 | HP:0000273 | |
| HumanPheno | Low hanging columella | 9.14e-04 | 56 | 18 | 3 | HP:0009765 | |
| HumanPheno | Increased body weight | 9.16e-04 | 491 | 18 | 7 | HP:0004324 | |
| HumanPheno | Hypertelorism | 9.33e-04 | 830 | 18 | 9 | HP:0000316 | |
| HumanPheno | Downslanted palpebral fissures | 9.85e-04 | 497 | 18 | 7 | HP:0000494 | |
| HumanPheno | Macule | 1.03e-03 | 234 | 18 | 5 | HP:0012733 | |
| HumanPheno | Duplication of phalanx of hallux | 1.05e-03 | 14 | 18 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 1.05e-03 | 14 | 18 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 1.05e-03 | 14 | 18 | 2 | HP:0002697 | |
| HumanPheno | Micrognathia | 1.05e-03 | 843 | 18 | 9 | HP:0000347 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | 1.07e-03 | 845 | 18 | 9 | HP:0009118 | |
| HumanPheno | Patent foramen ovale | 1.08e-03 | 135 | 18 | 4 | HP:0001655 | |
| HumanPheno | Irregular hyperpigmentation | 1.11e-03 | 238 | 18 | 5 | HP:0007400 | |
| HumanPheno | Abnormal earlobe morphology | 1.14e-03 | 137 | 18 | 4 | HP:0000363 | |
| HumanPheno | Pes planus | 1.15e-03 | 365 | 18 | 6 | HP:0001763 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 1.20e-03 | 368 | 18 | 6 | HP:0031432 | |
| HumanPheno | Duplication of phalanx of toe | 1.21e-03 | 15 | 18 | 2 | HP:0010181 | |
| HumanPheno | Social and occupational deterioration | 1.21e-03 | 15 | 18 | 2 | HP:0007086 | |
| HumanPheno | Perseverative thought | 1.36e-03 | 377 | 18 | 6 | HP:0030223 | |
| HumanPheno | Square face | 1.37e-03 | 16 | 18 | 2 | HP:0000321 | |
| HumanPheno | Abnormal pinna morphology | FANCD2 APC RPGRIP1 CHD8 CEP295 CEP152 RERE THOC2 CREBBP EP300 WNK3 | 1.46e-03 | 1299 | 18 | 11 | HP:0000377 |
| HumanPheno | Abnormality of the ureter | 1.48e-03 | 383 | 18 | 6 | HP:0000069 | |
| HumanPheno | Duplication involving bones of the feet | 1.49e-03 | 147 | 18 | 4 | HP:0009136 | |
| HumanPheno | Foot polydactyly | 1.49e-03 | 147 | 18 | 4 | HP:0001829 | |
| HumanPheno | Disordered formal thought process | 1.54e-03 | 386 | 18 | 6 | HP:0025769 | |
| HumanPheno | Premature thelarche | 1.55e-03 | 17 | 18 | 2 | HP:0010314 | |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 1.60e-03 | 150 | 18 | 4 | HP:0009601 | |
| HumanPheno | Missing ribs | 1.61e-03 | 68 | 18 | 3 | HP:0000921 | |
| HumanPheno | Joint dislocation | 1.63e-03 | 390 | 18 | 6 | HP:0001373 | |
| HumanPheno | Abnormality of the palmar creases | 1.65e-03 | 260 | 18 | 5 | HP:0010490 | |
| HumanPheno | Nystagmus | 1.70e-03 | 1102 | 18 | 10 | HP:0000639 | |
| HumanPheno | macules | 1.71e-03 | 262 | 18 | 5 | HP:0200031 | |
| HumanPheno | Facial hirsutism | 1.75e-03 | 18 | 18 | 2 | HP:0009937 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 1.80e-03 | 265 | 18 | 5 | HP:0001018 | |
| HumanPheno | Patellar dislocation | 1.82e-03 | 71 | 18 | 3 | HP:0002999 | |
| HumanPheno | Abnormality of the outer ear | FANCD2 APC RPGRIP1 CHD8 CEP295 CEP152 RERE THOC2 CREBBP EP300 WNK3 | 1.88e-03 | 1337 | 18 | 11 | HP:0000356 |
| HumanPheno | Abnormal mandible morphology | FANCD2 APC RPGRIP1 CHD8 CEP295 CEP152 RERE CREBBP EP300 WNK3 | 1.91e-03 | 1118 | 18 | 10 | HP:0000277 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | 1.93e-03 | 915 | 18 | 9 | HP:0009116 | |
| HumanPheno | Abnormal thought pattern | 1.95e-03 | 404 | 18 | 6 | HP:5200269 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | FANCD2 APC RPGRIP1 CHD8 CEP295 CEP152 RERE CREBBP EP300 WNK3 SIL1 | 1.96e-03 | 1343 | 18 | 11 | HP:0009115 |
| HumanPheno | Abnormal involuntary eye movements | 1.98e-03 | 1123 | 18 | 10 | HP:0012547 | |
| HumanPheno | Atypical scarring of skin | 2.05e-03 | 74 | 18 | 3 | HP:0000987 | |
| Domain | - | 5.93e-06 | 2 | 46 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 5.93e-06 | 2 | 46 | 2 | PF02135 | |
| Domain | ZF_TAZ | 5.93e-06 | 2 | 46 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 5.93e-06 | 2 | 46 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 5.93e-06 | 2 | 46 | 2 | PF08214 | |
| Domain | KIX | 5.93e-06 | 2 | 46 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 5.93e-06 | 2 | 46 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 5.93e-06 | 2 | 46 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 5.93e-06 | 2 | 46 | 2 | IPR013178 | |
| Domain | DUF902 | 5.93e-06 | 2 | 46 | 2 | PF06001 | |
| Domain | - | 5.93e-06 | 2 | 46 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 5.93e-06 | 2 | 46 | 2 | IPR010303 | |
| Domain | KAT11 | 5.93e-06 | 2 | 46 | 2 | SM01250 | |
| Domain | - | 5.93e-06 | 2 | 46 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 5.93e-06 | 2 | 46 | 2 | IPR000197 | |
| Domain | KIX_dom | 5.93e-06 | 2 | 46 | 2 | IPR003101 | |
| Domain | Creb_binding | 5.93e-06 | 2 | 46 | 2 | PF09030 | |
| Domain | KIX | 5.93e-06 | 2 | 46 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 5.93e-06 | 2 | 46 | 2 | PS51727 | |
| Domain | hnRNP_C | 8.85e-05 | 6 | 46 | 2 | IPR017347 | |
| Domain | Nuc_rcpt_coact | 8.85e-05 | 6 | 46 | 2 | IPR009110 | |
| Domain | Bromodomain | 1.11e-04 | 38 | 46 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.40e-04 | 41 | 46 | 3 | PS50014 | |
| Domain | BROMO | 1.50e-04 | 42 | 46 | 3 | SM00297 | |
| Domain | Bromodomain | 1.50e-04 | 42 | 46 | 3 | IPR001487 | |
| Domain | - | 1.50e-04 | 42 | 46 | 3 | 1.20.920.10 | |
| Domain | ZF_ZZ_2 | 8.85e-04 | 18 | 46 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 8.85e-04 | 18 | 46 | 2 | PS01357 | |
| Domain | ZZ | 8.85e-04 | 18 | 46 | 2 | PF00569 | |
| Domain | Znf_ZZ | 9.88e-04 | 19 | 46 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 9.88e-04 | 19 | 46 | 2 | SM00291 | |
| Domain | Chromo_domain | 1.58e-03 | 24 | 46 | 2 | IPR023780 | |
| Domain | Chromo | 1.86e-03 | 26 | 46 | 2 | PF00385 | |
| Domain | Bromodomain_CS | 1.86e-03 | 26 | 46 | 2 | IPR018359 | |
| Domain | CHROMO_2 | 2.15e-03 | 28 | 46 | 2 | PS50013 | |
| Domain | CHROMO_1 | 2.15e-03 | 28 | 46 | 2 | PS00598 | |
| Domain | Chromodomain-like | 2.81e-03 | 32 | 46 | 2 | IPR016197 | |
| Domain | CHROMO | 2.98e-03 | 33 | 46 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.98e-03 | 33 | 46 | 2 | IPR000953 | |
| Domain | BROMODOMAIN_1 | 3.74e-03 | 37 | 46 | 2 | PS00633 | |
| Domain | ARM-like | 4.33e-03 | 270 | 46 | 4 | IPR011989 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 5.22e-06 | 15 | 33 | 3 | MM1439 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 6.41e-06 | 16 | 33 | 3 | M8516 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 7.77e-06 | 17 | 33 | 3 | MM1509 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.10e-05 | 19 | 33 | 3 | M18933 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.29e-05 | 5 | 33 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 5.29e-05 | 5 | 33 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 5.29e-05 | 5 | 33 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 5.29e-05 | 5 | 33 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 7.92e-05 | 6 | 33 | 2 | M22062 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 9.39e-05 | 200 | 33 | 5 | M864 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.11e-04 | 7 | 33 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.47e-04 | 8 | 33 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.47e-04 | 8 | 33 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.47e-04 | 8 | 33 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.47e-04 | 8 | 33 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.89e-04 | 9 | 33 | 2 | M47451 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.92e-04 | 233 | 33 | 5 | M27099 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 2.36e-04 | 10 | 33 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.88e-04 | 11 | 33 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.88e-04 | 11 | 33 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.88e-04 | 11 | 33 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.46e-04 | 12 | 33 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.46e-04 | 12 | 33 | 2 | M27765 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 4.06e-04 | 151 | 33 | 4 | M19428 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 4.75e-04 | 14 | 33 | 2 | M27808 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.83e-04 | 158 | 33 | 4 | MM14791 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 5.47e-04 | 15 | 33 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 5.47e-04 | 15 | 33 | 2 | M10183 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 5.47e-04 | 15 | 33 | 2 | M953 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 5.51e-04 | 69 | 33 | 3 | M46439 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 6.25e-04 | 16 | 33 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 6.25e-04 | 16 | 33 | 2 | MM1420 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 6.25e-04 | 16 | 33 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 6.25e-04 | 16 | 33 | 2 | M27940 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 7.04e-04 | 75 | 33 | 3 | M641 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 7.07e-04 | 17 | 33 | 2 | M48025 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 7.94e-04 | 18 | 33 | 2 | M26942 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 8.49e-04 | 80 | 33 | 3 | M223 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 8.86e-04 | 19 | 33 | 2 | M46442 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 9.13e-04 | 82 | 33 | 3 | M594 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 9.44e-04 | 330 | 33 | 5 | M7847 | |
| Pathway | REACTOME_CELL_CYCLE | 9.46e-04 | 694 | 33 | 7 | M543 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.83e-04 | 20 | 33 | 2 | M27881 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.08e-03 | 87 | 33 | 3 | M27194 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.09e-03 | 21 | 33 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.09e-03 | 21 | 33 | 2 | M27485 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.19e-03 | 22 | 33 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.19e-03 | 22 | 33 | 2 | MM1370 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 1.30e-03 | 23 | 33 | 2 | MM1527 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 1.30e-03 | 23 | 33 | 2 | M39883 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.30e-03 | 23 | 33 | 2 | M2821 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 1.42e-03 | 24 | 33 | 2 | M16517 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.42e-03 | 24 | 33 | 2 | M13404 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2 | 1.44e-03 | 96 | 33 | 3 | M45026 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.44e-03 | 96 | 33 | 3 | M27784 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.54e-03 | 25 | 33 | 2 | M27880 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 1.54e-03 | 25 | 33 | 2 | MM15606 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.54e-03 | 25 | 33 | 2 | MM15608 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.67e-03 | 101 | 33 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.67e-03 | 101 | 33 | 3 | M39387 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.67e-03 | 26 | 33 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 1.67e-03 | 26 | 33 | 2 | M32 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.93e-03 | 28 | 33 | 2 | M27254 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.22e-03 | 30 | 33 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 2.22e-03 | 30 | 33 | 2 | M936 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.24e-03 | 239 | 33 | 4 | MM14756 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.52e-03 | 32 | 33 | 2 | M39521 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.52e-03 | 32 | 33 | 2 | MM14975 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.84e-03 | 34 | 33 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 2.84e-03 | 34 | 33 | 2 | M44 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 3.01e-03 | 35 | 33 | 2 | M48246 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 3.06e-03 | 125 | 33 | 3 | M45021 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 3.27e-03 | 128 | 33 | 3 | M48019 | |
| Pathway | REACTOME_GASTRULATION | 3.34e-03 | 129 | 33 | 3 | M46433 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 3.36e-03 | 37 | 33 | 2 | MM15683 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.54e-03 | 38 | 33 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.54e-03 | 38 | 33 | 2 | M27255 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.57e-03 | 272 | 33 | 4 | M29619 | |
| Pathway | PID_FOXM1_PATHWAY | 3.92e-03 | 40 | 33 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 3.92e-03 | 40 | 33 | 2 | M161 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 3.96e-03 | 137 | 33 | 3 | M145 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 4.19e-03 | 464 | 33 | 5 | M27547 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 4.21e-03 | 140 | 33 | 3 | M27484 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 4.32e-03 | 42 | 33 | 2 | M17541 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 4.32e-03 | 42 | 33 | 2 | M27272 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 4.38e-03 | 142 | 33 | 3 | M27233 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 4.46e-03 | 143 | 33 | 3 | M39591 | |
| Pathway | WP_MALE_INFERTILITY | 4.64e-03 | 145 | 33 | 3 | M39856 | |
| Pathway | PID_HNF3A_PATHWAY | 4.73e-03 | 44 | 33 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 4.73e-03 | 44 | 33 | 2 | M27295 | |
| Pathway | PID_PS1_PATHWAY | 5.16e-03 | 46 | 33 | 2 | M70 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.38e-03 | 47 | 33 | 2 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 5.60e-03 | 48 | 33 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.60e-03 | 48 | 33 | 2 | M611 | |
| Pathway | PID_FOXO_PATHWAY | 5.83e-03 | 49 | 33 | 2 | M136 | |
| Pathway | REACTOME_HEME_SIGNALING | 5.83e-03 | 49 | 33 | 2 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.83e-03 | 49 | 33 | 2 | M618 | |
| Pathway | REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY | 6.55e-03 | 52 | 33 | 2 | MM15536 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 6.55e-03 | 52 | 33 | 2 | M2404 | |
| Pathway | PID_NFAT_3PATHWAY | 6.80e-03 | 53 | 33 | 2 | M113 | |
| Pubmed | 1.97e-10 | 418 | 47 | 10 | 34709266 | ||
| Pubmed | FANCD2 NOLC1 CBX3 CHD8 CEP295 RERE ZFHX4 KDM5A SAP130 CREBBP EP300 ZMYND8 | 2.08e-08 | 1116 | 47 | 12 | 31753913 | |
| Pubmed | NOLC1 PSMD1 CHD8 CEP152 RERE ZFHX4 KDM5A SAP130 CREBBP EP300 SYNE2 SH3KBP1 ZMYND8 | 3.44e-08 | 1429 | 47 | 13 | 35140242 | |
| Pubmed | FAM133B NAV2 NOLC1 CBX3 RPGRIP1 PSMD1 CEP295 HNRNPCL1 KDM5A PPP1R12B HNRNPCL2 CNTRL SYNE2 | 3.82e-08 | 1442 | 47 | 13 | 35575683 | |
| Pubmed | 5.82e-08 | 75 | 47 | 5 | 25593309 | ||
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 1.32e-07 | 34 | 47 | 4 | 30894540 | |
| Pubmed | 2.68e-07 | 486 | 47 | 8 | 20936779 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.34e-07 | 695 | 47 | 9 | 23602568 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.17e-07 | 774 | 47 | 9 | 15302935 | |
| Pubmed | FANCD2 NOLC1 CBX3 CHD8 PPIG THOC2 SAP130 CREBBP EP300 ZMYND8 | 8.26e-07 | 1014 | 47 | 10 | 32416067 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FAM133B NOLC1 CBX3 CHD8 PPIG THOC2 KDM5A SAP130 NKAPD1 ADD2 ZMYND8 | 1.10e-06 | 1318 | 47 | 11 | 30463901 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.48e-06 | 1082 | 47 | 10 | 38697112 | |
| Pubmed | APC NOLC1 NRDE2 PSMD1 FAM216A CEP295 THOC2 NKAPD1 DDHD1 CNTRL | 1.51e-06 | 1084 | 47 | 10 | 11544199 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.79e-06 | 2 | 47 | 2 | 34845315 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19729597 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15860545 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.79e-06 | 2 | 47 | 2 | 24551300 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 33911074 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 9018065 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24648406 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30135524 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 1.79e-06 | 2 | 47 | 2 | 16596650 | |
| Pubmed | Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair. | 1.79e-06 | 2 | 47 | 2 | 28572115 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 1.79e-06 | 2 | 47 | 2 | 29217654 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20717166 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 10049825 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28386063 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 1.79e-06 | 2 | 47 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 1.79e-06 | 2 | 47 | 2 | 29170789 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25893291 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 11559821 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 1.79e-06 | 2 | 47 | 2 | 12646247 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 32576962 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19822209 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24522976 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.79e-06 | 2 | 47 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 1.79e-06 | 2 | 47 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.79e-06 | 2 | 47 | 2 | 34813504 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 1.79e-06 | 2 | 47 | 2 | 12696060 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 1.79e-06 | 2 | 47 | 2 | 36109165 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24639469 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 37816914 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 1.79e-06 | 2 | 47 | 2 | 11438528 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 10918613 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 31182547 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 35502657 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30635043 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 1.79e-06 | 2 | 47 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 1.79e-06 | 2 | 47 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 1.79e-06 | 2 | 47 | 2 | 27881443 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19272189 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 1.79e-06 | 2 | 47 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 1.79e-06 | 2 | 47 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 1.79e-06 | 2 | 47 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 1.79e-06 | 2 | 47 | 2 | 32690000 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 9733868 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30953353 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21803292 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 9811832 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 1.79e-06 | 2 | 47 | 2 | 33063428 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 34506759 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22177454 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 1.79e-06 | 2 | 47 | 2 | 39266679 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22303793 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 1.79e-06 | 2 | 47 | 2 | 34019788 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.96e-06 | 861 | 47 | 9 | 36931259 | |
| Pubmed | 2.11e-06 | 67 | 47 | 4 | 29254152 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.52e-06 | 289 | 47 | 6 | 23752268 | |
| Pubmed | 4.84e-06 | 503 | 47 | 7 | 16964243 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 5.36e-06 | 3 | 47 | 2 | 14716005 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18070920 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 5.36e-06 | 3 | 47 | 2 | 21967847 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 5.36e-06 | 3 | 47 | 2 | 19252086 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 27903646 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 12748286 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 10075656 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 24340053 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 19273602 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 15649887 | ||
| Pubmed | Expression patterns of histone acetyltransferases p300 and CBP during murine tooth development. | 5.36e-06 | 3 | 47 | 2 | 22179676 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 17410209 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 5.36e-06 | 3 | 47 | 2 | 26951377 | |
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 5.36e-06 | 3 | 47 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 5.36e-06 | 3 | 47 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 5.36e-06 | 3 | 47 | 2 | 16237459 | |
| Pubmed | A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. | 5.36e-06 | 3 | 47 | 2 | 12384703 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 10350644 | ||
| Interaction | HDAC1 interactions | FANCD2 SFMBT1 APC NOLC1 PSMD1 CHD8 RERE ZFHX4 KDM5A SAP130 CREBBP EP300 SYNE2 ZMYND8 S100PBP | 1.65e-08 | 1108 | 47 | 15 | int:HDAC1 |
| Interaction | KDM1A interactions | FANCD2 SFMBT1 APC CBX3 PSMD1 CHD8 CEP152 RERE ZFHX4 THOC2 KDM5A EP300 ZMYND8 S100PBP | 1.72e-08 | 941 | 47 | 14 | int:KDM1A |
| Interaction | HNRNPCL1 interactions | 1.94e-06 | 161 | 47 | 6 | int:HNRNPCL1 | |
| Interaction | MYBL2 interactions | 2.01e-06 | 162 | 47 | 6 | int:MYBL2 | |
| Interaction | TPX2 interactions | 7.60e-06 | 204 | 47 | 6 | int:TPX2 | |
| Interaction | ZC3H11A interactions | 1.02e-05 | 215 | 47 | 6 | int:ZC3H11A | |
| Interaction | CEBPD interactions | 1.31e-05 | 62 | 47 | 4 | int:CEBPD | |
| Interaction | PHF21A interactions | 1.36e-05 | 343 | 47 | 7 | int:PHF21A | |
| Interaction | CDK12 interactions | 1.43e-05 | 228 | 47 | 6 | int:CDK12 | |
| Interaction | KLF13 interactions | 1.54e-05 | 21 | 47 | 3 | int:KLF13 | |
| Interaction | TP53BP2 interactions | 1.96e-05 | 241 | 47 | 6 | int:TP53BP2 | |
| Interaction | HMG20A interactions | 2.10e-05 | 244 | 47 | 6 | int:HMG20A | |
| Interaction | MECP2 interactions | APC NOLC1 CBX3 NRDE2 PPIG HNRNPCL1 THOC2 KDM5A NKAPD1 EP300 ADD2 ZMYND8 | 2.82e-05 | 1287 | 47 | 12 | int:MECP2 |
| Interaction | HOXB7 interactions | 2.98e-05 | 26 | 47 | 3 | int:HOXB7 | |
| Interaction | ZNF532 interactions | 3.34e-05 | 27 | 47 | 3 | int:ZNF532 | |
| Interaction | YWHAH interactions | FANCD2 NAV2 APC NOLC1 CEP152 KDM5A CREBBP WNK3 CNTRL SYNE2 PLEKHA3 | 3.51e-05 | 1102 | 47 | 11 | int:YWHAH |
| Interaction | HNF1A interactions | 3.61e-05 | 80 | 47 | 4 | int:HNF1A | |
| Interaction | SETD1A interactions | 4.64e-05 | 170 | 47 | 5 | int:SETD1A | |
| Interaction | RBBP4 interactions | 4.81e-05 | 573 | 47 | 8 | int:RBBP4 | |
| Interaction | GSC interactions | 5.02e-05 | 87 | 47 | 4 | int:GSC | |
| Interaction | PPP1R13L interactions | 5.24e-05 | 88 | 47 | 4 | int:PPP1R13L | |
| Interaction | CHD3 interactions | 5.37e-05 | 757 | 47 | 9 | int:CHD3 | |
| Interaction | VPS4A interactions | 5.98e-05 | 91 | 47 | 4 | int:VPS4A | |
| Interaction | XAB2 interactions | 7.11e-05 | 186 | 47 | 5 | int:XAB2 | |
| Interaction | PELP1 interactions | 7.67e-05 | 189 | 47 | 5 | int:PELP1 | |
| Interaction | ERICH3 interactions | 7.94e-05 | 6 | 47 | 2 | int:ERICH3 | |
| Interaction | HOXB2 interactions | 8.04e-05 | 36 | 47 | 3 | int:HOXB2 | |
| Interaction | ZMYND8 interactions | 8.06e-05 | 191 | 47 | 5 | int:ZMYND8 | |
| Interaction | IRF7 interactions | 8.64e-05 | 100 | 47 | 4 | int:IRF7 | |
| Interaction | CSNK2B interactions | 8.84e-05 | 625 | 47 | 8 | int:CSNK2B | |
| Interaction | TNK2 interactions | 8.89e-05 | 195 | 47 | 5 | int:TNK2 | |
| Interaction | PHIP interactions | 9.32e-05 | 197 | 47 | 5 | int:PHIP | |
| Interaction | TRA2A interactions | 1.12e-04 | 330 | 47 | 6 | int:TRA2A | |
| Interaction | DDX23 interactions | 1.15e-04 | 480 | 47 | 7 | int:DDX23 | |
| Interaction | SEC24C interactions | 1.18e-04 | 207 | 47 | 5 | int:SEC24C | |
| Interaction | CNOT3 interactions | 1.18e-04 | 207 | 47 | 5 | int:CNOT3 | |
| Interaction | TFF1 interactions | 1.19e-04 | 41 | 47 | 3 | int:TFF1 | |
| Interaction | ECPAS interactions | 1.26e-04 | 337 | 47 | 6 | int:ECPAS | |
| Interaction | GPATCH1 interactions | 1.30e-04 | 111 | 47 | 4 | int:GPATCH1 | |
| Interaction | RCOR1 interactions | 1.37e-04 | 494 | 47 | 7 | int:RCOR1 | |
| Interaction | HMGXB4 interactions | 1.39e-04 | 113 | 47 | 4 | int:HMGXB4 | |
| Interaction | TRADD interactions | 1.39e-04 | 113 | 47 | 4 | int:TRADD | |
| Interaction | LOXHD1 interactions | 1.48e-04 | 8 | 47 | 2 | int:LOXHD1 | |
| Interaction | TBXT interactions | 1.54e-04 | 116 | 47 | 4 | int:TBXT | |
| Interaction | CLK3 interactions | 1.56e-04 | 220 | 47 | 5 | int:CLK3 | |
| Interaction | MXD1 interactions | 1.57e-04 | 45 | 47 | 3 | int:MXD1 | |
| Interaction | MORF4L1 interactions | 1.60e-04 | 221 | 47 | 5 | int:MORF4L1 | |
| Interaction | RBBP7 interactions | 1.61e-04 | 507 | 47 | 7 | int:RBBP7 | |
| Interaction | PIAS1 interactions | 1.62e-04 | 353 | 47 | 6 | int:PIAS1 | |
| Interaction | ERG interactions | 1.67e-04 | 223 | 47 | 5 | int:ERG | |
| Interaction | USP7 interactions | FANCD2 NAV2 APC TEX15 THOC2 SAP130 CREBBP EP300 WNK3 SH3KBP1 ZMYND8 | 1.70e-04 | 1313 | 47 | 11 | int:USP7 |
| Interaction | HOXB3 interactions | 1.90e-04 | 9 | 47 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 1.90e-04 | 9 | 47 | 2 | int:ARGFX | |
| Interaction | PTGS2 interactions | 1.91e-04 | 48 | 47 | 3 | int:PTGS2 | |
| Interaction | SAMD1 interactions | 1.92e-04 | 123 | 47 | 4 | int:SAMD1 | |
| Interaction | RSF1 interactions | 1.98e-04 | 124 | 47 | 4 | int:RSF1 | |
| Interaction | HOXB9 interactions | 1.98e-04 | 124 | 47 | 4 | int:HOXB9 | |
| Interaction | PAX7 interactions | 1.98e-04 | 124 | 47 | 4 | int:PAX7 | |
| Interaction | FOXO3 interactions | 1.98e-04 | 124 | 47 | 4 | int:FOXO3 | |
| Interaction | CDC40 interactions | 1.98e-04 | 124 | 47 | 4 | int:CDC40 | |
| Interaction | H3C1 interactions | 2.02e-04 | 901 | 47 | 9 | int:H3C1 | |
| Interaction | UBTF interactions | 2.08e-04 | 234 | 47 | 5 | int:UBTF | |
| Interaction | PPIG interactions | 2.18e-04 | 127 | 47 | 4 | int:PPIG | |
| Interaction | HAUS8 interactions | 2.18e-04 | 127 | 47 | 4 | int:HAUS8 | |
| Interaction | MKRN2 interactions | 2.59e-04 | 385 | 47 | 6 | int:MKRN2 | |
| Interaction | CDC16 interactions | 2.63e-04 | 246 | 47 | 5 | int:CDC16 | |
| Interaction | IRF5 interactions | 2.71e-04 | 54 | 47 | 3 | int:IRF5 | |
| Interaction | ISY1 interactions | 2.75e-04 | 135 | 47 | 4 | int:ISY1 | |
| Interaction | ASF1A interactions | 2.78e-04 | 249 | 47 | 5 | int:ASF1A | |
| Interaction | FHL2 interactions | 3.01e-04 | 396 | 47 | 6 | int:FHL2 | |
| Interaction | NR2C2 interactions | FAM133B NOLC1 CBX3 CHD8 PPIG THOC2 KDM5A SAP130 NKAPD1 ADD2 ZMYND8 | 3.02e-04 | 1403 | 47 | 11 | int:NR2C2 |
| Interaction | DNMT1 interactions | 3.04e-04 | 254 | 47 | 5 | int:DNMT1 | |
| Interaction | RBPJ interactions | 3.04e-04 | 254 | 47 | 5 | int:RBPJ | |
| Interaction | PSME3 interactions | 3.09e-04 | 398 | 47 | 6 | int:PSME3 | |
| Interaction | CSNK2A1 interactions | 3.14e-04 | 956 | 47 | 9 | int:CSNK2A1 | |
| Interaction | HEY1 interactions | 3.16e-04 | 140 | 47 | 4 | int:HEY1 | |
| Interaction | CASC3 interactions | 3.33e-04 | 142 | 47 | 4 | int:CASC3 | |
| Interaction | MAF interactions | 3.71e-04 | 60 | 47 | 3 | int:MAF | |
| Interaction | NPM1 interactions | FANCD2 CBX3 PSMD1 CHD8 CEP152 TEX15 THOC2 EP300 SYNE2 ZMYND8 | 3.72e-04 | 1201 | 47 | 10 | int:NPM1 |
| Interaction | ATRX interactions | 3.83e-04 | 267 | 47 | 5 | int:ATRX | |
| Interaction | ATAD2 interactions | 3.89e-04 | 61 | 47 | 3 | int:ATAD2 | |
| Interaction | AMER1 interactions | 3.89e-04 | 61 | 47 | 3 | int:AMER1 | |
| Interaction | STK17B interactions | 4.08e-04 | 62 | 47 | 3 | int:STK17B | |
| Interaction | SRSF7 interactions | 4.39e-04 | 425 | 47 | 6 | int:SRSF7 | |
| Interaction | CTNNB1 interactions | 4.66e-04 | 1009 | 47 | 9 | int:CTNNB1 | |
| Interaction | S100P interactions | 4.68e-04 | 279 | 47 | 5 | int:S100P | |
| Interaction | PPIE interactions | 4.91e-04 | 282 | 47 | 5 | int:PPIE | |
| Interaction | PRPF38A interactions | 5.36e-04 | 161 | 47 | 4 | int:PRPF38A | |
| Interaction | MBD2 interactions | 5.36e-04 | 161 | 47 | 4 | int:MBD2 | |
| Interaction | KIF23 interactions | 5.44e-04 | 1031 | 47 | 9 | int:KIF23 | |
| Interaction | KLF2 interactions | 5.48e-04 | 15 | 47 | 2 | int:KLF2 | |
| Interaction | PRPF3 interactions | 5.66e-04 | 291 | 47 | 5 | int:PRPF3 | |
| Interaction | NUP43 interactions | 5.71e-04 | 625 | 47 | 7 | int:NUP43 | |
| Interaction | FOSL1 interactions | 5.83e-04 | 70 | 47 | 3 | int:FOSL1 | |
| Interaction | MFAP1 interactions | 6.03e-04 | 295 | 47 | 5 | int:MFAP1 | |
| Interaction | PTF1A interactions | 6.26e-04 | 16 | 47 | 2 | int:PTF1A | |
| Interaction | MOB1A interactions | 6.33e-04 | 72 | 47 | 3 | int:MOB1A | |
| Interaction | ZC3H14 interactions | 6.43e-04 | 169 | 47 | 4 | int:ZC3H14 | |
| Interaction | BAZ2A interactions | 6.59e-04 | 73 | 47 | 3 | int:BAZ2A | |
| Interaction | EGR2 interactions | 6.72e-04 | 171 | 47 | 4 | int:EGR2 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.90e-04 | 17 | 22 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.14e-04 | 18 | 22 | 2 | 91 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.32e-03 | 181 | 22 | 3 | 694 | |
| GeneFamily | Sterile alpha motif domain containing | 5.08e-03 | 88 | 22 | 2 | 760 | |
| GeneFamily | PHD finger proteins | 5.31e-03 | 90 | 22 | 2 | 88 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.57e-02 | 206 | 22 | 2 | 682 | |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP | 9.93e-06 | 160 | 47 | 5 | M8183 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 2.77e-05 | 198 | 47 | 5 | M8624 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_DN | 2.77e-05 | 198 | 47 | 5 | M5398 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 2.84e-05 | 199 | 47 | 5 | M7530 | |
| Coexpression | RICKMAN_METASTASIS_UP | 3.68e-05 | 350 | 47 | 6 | M9752 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.67e-07 | 151 | 46 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.87e-06 | 210 | 46 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.96e-06 | 127 | 46 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | FANCD2 SFMBT1 DGKD CEP295 TEX15 KDM5A WNK3 DDHD1 PPP1R12B S100PBP | 8.05e-06 | 820 | 46 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | FANCD2 APC NOLC1 FHOD3 PPIG CEP295 GCFC2 THOC2 NKAPD1 WNK3 ADD2 CNTRL SYNE2 | 8.62e-06 | 1459 | 46 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.87e-06 | 230 | 46 | 6 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | FANCD2 APC NOLC1 FHOD3 PPIG CEP295 GCFC2 THOC2 NKAPD1 WNK3 CNTRL SYNE2 | 1.04e-05 | 1257 | 46 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | FANCD2 SFMBT1 APC FHOD3 PPIG CEP295 GCFC2 KDM5A WNK3 CNTRL SYNE2 | 1.21e-05 | 1060 | 46 | 11 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 1.79e-05 | 150 | 46 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.71e-05 | 275 | 46 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | FANCD2 SFMBT1 APC FHOD3 PPIG CEP295 GCFC2 KDM5A WNK3 ADD2 CNTRL SYNE2 | 3.38e-05 | 1414 | 46 | 12 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.70e-05 | 595 | 46 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 3.70e-05 | 778 | 46 | 9 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 8.45e-05 | 107 | 46 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 2.34e-04 | 776 | 46 | 8 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 4.14e-04 | 67 | 46 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.77e-08 | 182 | 47 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.29e-08 | 186 | 47 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.04e-08 | 197 | 47 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.87e-06 | 194 | 47 | 5 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.12e-06 | 199 | 47 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.02e-05 | 169 | 47 | 4 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-05 | 170 | 47 | 4 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 171 | 47 | 4 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 184 | 47 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.48e-05 | 187 | 47 | 4 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.58e-05 | 188 | 47 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.07e-05 | 193 | 47 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.60e-05 | 198 | 47 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 5.60e-05 | 198 | 47 | 4 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.71e-05 | 199 | 47 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.71e-05 | 199 | 47 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.71e-05 | 199 | 47 | 4 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.71e-05 | 199 | 47 | 4 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.71e-05 | 199 | 47 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 5.82e-05 | 200 | 47 | 4 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 5.82e-05 | 200 | 47 | 4 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-05 | 200 | 47 | 4 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 5.82e-05 | 200 | 47 | 4 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-05 | 200 | 47 | 4 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-dn_T|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.82e-05 | 200 | 47 | 4 | 1aa298dd7172e023adf569c32e49f69fa8d9c7ff | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.89e-04 | 122 | 47 | 3 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 4.15e-04 | 138 | 47 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.51e-04 | 142 | 47 | 3 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.09e-04 | 148 | 47 | 3 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-04 | 165 | 47 | 3 | 475905d608fac628960188ae4a18010b8097417e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.35e-04 | 168 | 47 | 3 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-04 | 168 | 47 | 3 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-04 | 168 | 47 | 3 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 8.00e-04 | 173 | 47 | 3 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.00e-04 | 173 | 47 | 3 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 8.27e-04 | 175 | 47 | 3 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 8.27e-04 | 175 | 47 | 3 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-04 | 177 | 47 | 3 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-04 | 178 | 47 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-04 | 179 | 47 | 3 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-04 | 179 | 47 | 3 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.83e-04 | 179 | 47 | 3 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.83e-04 | 179 | 47 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | de87503d9caac3ebc80ab8090c1a9ee5a925b2a0 | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.97e-04 | 180 | 47 | 3 | e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 181 | 47 | 3 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 181 | 47 | 3 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 9.12e-04 | 181 | 47 | 3 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 9.26e-04 | 182 | 47 | 3 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.41e-04 | 183 | 47 | 3 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 9.41e-04 | 183 | 47 | 3 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 9.41e-04 | 183 | 47 | 3 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.71e-04 | 185 | 47 | 3 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-04 | 185 | 47 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.71e-04 | 185 | 47 | 3 | 6e7fefdd65d30abaffb26b92b0d04e1630d262ad | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 9.71e-04 | 185 | 47 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 9.71e-04 | 185 | 47 | 3 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.71e-04 | 185 | 47 | 3 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.71e-04 | 185 | 47 | 3 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 9.86e-04 | 186 | 47 | 3 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-04 | 186 | 47 | 3 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-04 | 186 | 47 | 3 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.86e-04 | 186 | 47 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.86e-04 | 186 | 47 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-04 | 186 | 47 | 3 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 187 | 47 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-03 | 187 | 47 | 3 | cfdc1585c80d2bb475d9145395fb50a88c53f838 | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.00e-03 | 187 | 47 | 3 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-03 | 188 | 47 | 3 | 2b8d70f761eda5509f21845a87cdb3602a639dd7 | |
| ToppCell | 3'_v3-GI_small-bowel|World / Manually curated celltypes from each tissue | 1.02e-03 | 188 | 47 | 3 | 822c6abaf7bcd6721269bdbd1f2b286ccf0aec1a | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 1.03e-03 | 189 | 47 | 3 | f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.03e-03 | 189 | 47 | 3 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.03e-03 | 189 | 47 | 3 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.03e-03 | 189 | 47 | 3 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.03e-03 | 189 | 47 | 3 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-03 | 189 | 47 | 3 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.05e-03 | 190 | 47 | 3 | 1f890be1ac8613a098b271945f25a58c3c2530ab | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-03 | 190 | 47 | 3 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.05e-03 | 190 | 47 | 3 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-03 | 190 | 47 | 3 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.05e-03 | 190 | 47 | 3 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.05e-03 | 190 | 47 | 3 | 693b223f6b94a46d935fbcb02d7a27340ce43154 | |
| ToppCell | ASK454-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.05e-03 | 190 | 47 | 3 | 5cea6480f08253d7adf484e511d3fdfa96641268 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 190 | 47 | 3 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-03 | 190 | 47 | 3 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.05e-03 | 190 | 47 | 3 | d7cecf88451f736f8f3f6f4644504cf22846cd6e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-03 | 190 | 47 | 3 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.05e-03 | 190 | 47 | 3 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-03 | 190 | 47 | 3 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.05e-03 | 190 | 47 | 3 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.05e-03 | 190 | 47 | 3 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-03 | 191 | 47 | 3 | 7ad9b7a77d8a803011306a7f716f62b19b7dc556 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.06e-03 | 191 | 47 | 3 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-03 | 191 | 47 | 3 | 913cbdd370e0bcc57038dc4c78a4b6d7ac420b5d | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 1.06e-03 | 191 | 47 | 3 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.06e-03 | 191 | 47 | 3 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_CTL|COVID-19_Severe / Disease group, lineage and cell class | 1.06e-03 | 191 | 47 | 3 | ca138cc2224b32dd08cf98ead00188bcfb1a9b69 | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 3.20e-06 | 198 | 47 | 6 | 2197_UP | |
| Disease | Menke-Hennekam syndrome | 2.38e-06 | 2 | 46 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.38e-06 | 2 | 46 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.38e-06 | 2 | 46 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.38e-06 | 2 | 46 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.38e-06 | 2 | 46 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.38e-06 | 2 | 46 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.38e-06 | 2 | 46 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.38e-06 | 2 | 46 | 2 | C0035934 | |
| Disease | Benign tumor of pancreas | 1.83e-04 | 13 | 46 | 2 | C0347284 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.81e-04 | 16 | 46 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma | 4.00e-04 | 19 | 46 | 2 | C0235974 | |
| Disease | Colorectal cancer | 8.14e-04 | 27 | 46 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 8.14e-04 | 27 | 46 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 8.14e-04 | 27 | 46 | 2 | cv:C0009404 | |
| Disease | plasma betaine measurement | 1.29e-03 | 34 | 46 | 2 | EFO_0007787 | |
| Disease | Mental Retardation, Psychosocial | 1.34e-03 | 139 | 46 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 1.34e-03 | 139 | 46 | 3 | C0020796 | |
| Disease | Mental deficiency | 1.34e-03 | 139 | 46 | 3 | C0917816 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEDKQDMKTASSTSS | 571 | Q5RHP9 | |
| KMESTETEERSTELK | 1006 | Q09472 | |
| TTSAEKDKDKREDTL | 271 | Q96KC9 | |
| SSSSTDESEDEKEEK | 2091 | Q9HCK8 | |
| KDEKSIEVETKTDTS | 586 | O94986 | |
| ERESEESKLETSKVT | 1956 | Q7Z7A1 | |
| RKSLSDSESDDSKSK | 91 | Q13185 | |
| EERKKEESTAASETT | 1561 | Q92793 | |
| SEEESSSSEEEKTKK | 426 | Q14978 | |
| SSSEEEEEKTSKSAV | 476 | Q14978 | |
| SSSDSSEDKDEKISE | 56 | P0C860 | |
| EEEQSSSSMKKDETH | 221 | O60812 | |
| EEEQSSSSMKKDETH | 221 | B2RXH8 | |
| SLSSTSEDSEKDEKD | 3721 | Q2LD37 | |
| SSSRSETDTDSEKDK | 106 | Q9H7Z3 | |
| DMKDTASVKSSSSLE | 1356 | P29375 | |
| SSDSESATEEKSKKR | 216 | Q13427 | |
| ADEITKETTEKTKDS | 441 | Q9NR20 | |
| KSSESSMSETESDSK | 141 | Q5BKY9 | |
| SMSETESDSKDSLKK | 146 | Q5BKY9 | |
| FMDSSVEDSKKESSS | 531 | P16383 | |
| KTKEEISTDSETDLS | 3026 | Q8N3K9 | |
| SSSSSTLEREEKEDK | 631 | Q2V2M9 | |
| TESSEESEVMAKKCS | 526 | Q16760 | |
| TQSSETSKDSMEDEK | 771 | Q8NEL9 | |
| SSDDSESHMSEEKKE | 236 | Q8WUB2 | |
| SEHMDDSKQESTTSK | 1986 | Q9C0D2 | |
| EKETSAEKSKESGST | 1106 | Q9ULU4 | |
| DKDETDSSKDTEKLS | 161 | Q96BU1 | |
| EDKESLTEDASKTRK | 11 | Q9BXW9 | |
| SEKTEDSRTTVASDK | 246 | Q3MIW9 | |
| TSKEDELSESKEKST | 191 | Q9HCH5 | |
| DTKDSSKISSEEEKA | 946 | Q96KN7 | |
| SKEEKATVEFSTDMS | 691 | Q8WXH0 | |
| SDVSDESDKSTSGKK | 1036 | Q8IVL1 | |
| DSSKTEMDSRTKSKD | 256 | Q96B97 | |
| EKDSDSMETEEKTSS | 291 | Q99460 | |
| SSTKETERKETKAEE | 46 | Q9H173 | |
| SDTEEADRTSSKKTK | 656 | Q9P2R6 | |
| SSSSDEETSKEMEVK | 146 | Q14201 | |
| TSADTDVDTSKDKTE | 671 | P35612 | |
| ASSESSEKAKSEDEK | 2576 | P25054 | |
| KSKKEATDITADSSS | 171 | Q6ZUT1 | |
| SSSEESEERDTKKTK | 236 | Q6ZUT1 | |
| ETKEDKSTATESTKE | 3316 | Q86UP3 | |
| ASKSDESSTEETDKS | 1216 | Q8NI27 | |
| METNSTDDEKSTAKS | 851 | Q9H0E3 | |
| TDTRTKKEKEISETS | 96 | Q9HB20 | |
| QEESEMSEKKSCSSS | 726 | Q9UHJ3 | |
| EITKSSTSTIKDKDE | 306 | Q9BXT5 | |
| KSVEMTEDDKVAESS | 61 | Q9BYP7 | |
| KSQEMEEENKESSSS | 346 | O60237 |